Werner Rabitsch

Long-term survival after allogeneic stem cell transplantation in patients with acute myeloid leukemia

Abstract Allogeneic hematopoietic cell transplantation (HCT) is the only curative treatment for patients with higher-risk acute myeloid leukemia (AML), but survival is limited by recurrent malignancy and complications such as organ toxicity and infections. This study evaluated ov...